Q1 Earnings Forecast for CGEM Issued By William Blair
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) – William Blair issued their Q1 2026 EPS estimates for Cullinan Therapeutics in a report issued on Thursday, February 27th. William Blair analyst M. Phipps expects that the company will post earnings of ($0.69) per share for the quarter. The consensus estimate for Cullinan Therapeutics’ current full-year earnings […]
